Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;269(5):2673-2686.
doi: 10.1007/s00415-021-10831-z. Epub 2021 Oct 27.

Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative disease

Affiliations

Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative disease

F Elizabeth Godkin et al. J Neurol. 2022 May.

Abstract

Background: Remote health monitoring with wearable sensor technology may positively impact patient self-management and clinical care. In individuals with complex health conditions, multi-sensor wear may yield meaningful information about health-related behaviors. Despite available technology, feasibility of device-wearing in daily life has received little attention in persons with physical or cognitive limitations. This mixed methods study assessed the feasibility of continuous, multi-sensor wear in persons with cerebrovascular (CVD) or neurodegenerative disease (NDD).

Methods: Thirty-nine participants with CVD, Alzheimer's disease/amnestic mild cognitive impairment, frontotemporal dementia, Parkinson's disease, or amyotrophic lateral sclerosis (median age 68 (45-83) years, 36% female) wore five devices (bilateral ankles and wrists, chest) continuously for a 7-day period. Adherence to device wearing was quantified by examining volume and pattern of device removal (non-wear). A thematic analysis of semi-structured de-brief interviews with participants and study partners was used to examine user acceptance.

Results: Adherence to multi-sensor wear, defined as a minimum of three devices worn concurrently, was high (median 98.2% of the study period). Non-wear rates were low across all sensor locations (median 17-22 min/day), with significant differences between some locations (p = 0.006). Multi-sensor non-wear was higher for daytime versus nighttime wear (p < 0.001) and there was a small but significant increase in non-wear over the collection period (p = 0.04). Feedback from de-brief interviews suggested that multi-sensor wear was generally well accepted by both participants and study partners.

Conclusion: A continuous, multi-sensor remote health monitoring approach is feasible in a cohort of persons with CVD or NDD.

Keywords: Adherence; Cerebrovascular disease; Neurodegenerative disease; Remote monitoring; User acceptance; Wearable sensors.

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Multi-modal, multi-nodal device–sensor relationship and participant set up. a Limb (GENEActiv) and chest (Bittium Faros 180) devices worn within this study, with the corresponding sensors and body location(s) and b Schematic representation of device location on body segments. The multi-modal, multi-nodal approach enables simultaneous assessment of multiple domains of health in persons living with cerebrovascular and neurodegenerative disease
Fig. 2
Fig. 2
Participants’ average non-wear rate by wear location (n = 37). The data collection window was defined as 2:00 pm on the day of the baseline visit to 2:00 pm on Day 4, resulting in four consecutive 24-h periods. Grey symbols denote individual participants. Black symbols denote the four participants deemed to be outliers across two or more wear locations. White symbols denote participant outliers for a single wear location. Non-wear rate was significantly different dependent upon wear location (p = 0.006) and post-hoc testing revealed a significant difference between the chest compared to the left wrist (p = 0.03) and right wrist (p = 0.02). Note: symbols appearing across figures do not denote the same participant
Fig. 3
Fig. 3
Non-wear rate based on time of day (a) and day of collection (b) (n = 37). Data represent periods of time when less than three devices were worn (multi-sensor non-wear). The data collection window in these analyses was defined as 2:00 pm on the day of the baseline visit to 2:00 pm on Day 6, resulting in six consecutive 24-h periods. Black symbols denote the participants deemed to be outliers across two or more data points. White symbols denote participant outliers for a single data point. Non-wear rate was significantly different based on time of day (p < 0.001) and increased across the wear period (p = 0.04)
Fig. 4
Fig. 4
Pattern and total rate of non-wear across and within individual study participants (n = 37). Data represent periods of time when less than three devices were worn (multi-sensor non-wear). a Total non-wear rates for each participant, sorted from least (top) to most (bottom) and b Non-wear periods for each day of data collection. Width of the bar denotes bout duration. Shaded grey sections denote nighttime periods (11:00 pm to 7:00am)

Similar articles

Cited by

References

    1. Morgan C, Rolinski M, McNaney R, et al. Systematic review looking at the use of technology to measure free-living symptom and activity outcomes in Parkinson’s disease in the home or a home-like environment. J Parkinsons Dis. 2020;10:429–454. doi: 10.3233/JPD-191781. - DOI - PMC - PubMed
    1. Bonato P. Wearable sensors and systems: from enabling technology to clinical applications. IEEE Eng Med Biol Mag. 2010;29:25–36. doi: 10.1109/MEMB.2010.936554. - DOI - PubMed
    1. Del Din S, Godfrey A, Mazzà C, et al. Free-living monitoring of Parkinson’s disease: lessons from the field. Mov Disord. 2016;31:1293–1313. doi: 10.1002/mds.26718. - DOI - PubMed
    1. Mancini M, Shah VV, Stuart S, et al. Measuring freezing of gait during daily-life: an open-source, wearable sensors approach. J Neuroeng Rehabil. 2021;18:1–13. doi: 10.1186/s12984-020-00774-3. - DOI - PMC - PubMed
    1. Papapetropoulos S, Mitsi G, Espay AJ. Digital health revolution: is it time for affordable remote monitoring for Parkinson’s disease? Front Neurol. 2015;6:1–3. doi: 10.3389/fneur.2015.00034. - DOI - PMC - PubMed